Albumin-bound Paclitaxel Combination With Capecitabine Versus Capecitabine Monotherapy in Paclitaxel/Docetaxel-resistant Advanced Breast Cancer
Clinical trial NCT04780347 · UNKNOWN
Trial details
- NCT number
- NCT04780347
- Sponsor
- Fudan University
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-12-15
- Primary completion
- 2022-12-30
- Enrollment
- 92
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.